IGM Biosciences, Inc. Quarterly Debt-to-equity in % from Q2 2020 to Q4 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
IGM Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q2 2020 to Q4 2024.
  • IGM Biosciences, Inc. Debt-to-equity for the quarter ending December 31, 2024 was 212 %, a 129% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2024 212 +120 +129% Dec 31, 2024
Q3 2024 155 +68.8 +80.1% Sep 30, 2024
Q2 2024 117 +38 +47.8% Jun 30, 2024
Q1 2024 100 +29.4 +41.7% Mar 31, 2024
Q4 2023 92.8 +34.3 +58.6% Dec 31, 2023
Q3 2023 85.9 +40.2 +88.2% Sep 30, 2023
Q2 2023 79.4 +47 +145% Jun 30, 2023
Q1 2023 70.6 +53.5 +312% Mar 31, 2023
Q4 2022 58.5 +45.8 +362% Dec 31, 2022
Q3 2022 45.6 +36.2 +385% Sep 30, 2022
Q2 2022 32.4 +24.1 +291% Jun 30, 2022
Q1 2022 17.2 +8.55 +99.5% Mar 31, 2022
Q4 2021 12.7 +3.5 +38.2% Dec 31, 2021
Q3 2021 9.41 -0.59 -5.9% Sep 30, 2021
Q2 2021 8.29 -0.09 -1.07% Jun 30, 2021
Q1 2021 8.59 Mar 31, 2021
Q4 2020 9.15 Dec 31, 2020
Q3 2020 10 Sep 30, 2020
Q2 2020 8.38 Jun 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.